X
Xenon Pharmaceuticals D
D
XENE
30.300
USD
-0.71
(-2.29%)
مغلق
حجم التداول
51,811
الربح لكل سهم
-4
العائد الربحي
-
P/E
-9
حجم السوق
2,325,028,050
الأخبار المقالات
العنوان: Xenon Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.